Targeting long noncoding RNAs in neuroblastoma: Progress and prospects

Area of Science:

• Oncology
• Molecular Biology
• Genetics

Background:

• Neuroblastoma (NB) is a prevalent childhood cancer with poor survival rates in high-risk patients.
• Long noncoding RNAs (lncRNAs) are increasingly recognized for their roles in cancer development.
• Research into lncRNAs in NB pathogenesis is a recent but rapidly growing field.

Purpose of the Study:

• To review the current understanding of lncRNA involvement in neuroblastoma.
• To discuss the pathological roles of lncRNAs in NB development.
• To explore the potential of lncRNAs as biomarkers for NB prognosis and treatment.

Main Methods:

• Literature review of studies investigating lncRNAs in neuroblastoma.
• Analysis of the functional and pathological implications of dysregulated lncRNAs in NB.
• Synthesis of current evidence on lncRNA-based biomarkers for NB.

Main Results:

• lncRNAs are implicated in the pathogenesis of neuroblastoma.
• Specific lncRNAs exhibit dysregulation that correlates with NB development.
• Several lncRNAs show potential as diagnostic or prognostic biomarkers.

Conclusions:

• lncRNAs represent a promising area for understanding and potentially treating neuroblastoma.
• Further research into lncRNA function is crucial for clinical applications.
• lncRNAs may offer novel therapeutic targets and biomarkers for neuroblastoma.